ENTITY

Syncell (SYNCELL TT)

1
Analysis
Health CareTaiwan
The company develops a spatial biology system designed for high-content de novo spatial proteomics. The company's technology converts high-content microscopes into precision photolabeling machines, enabling the identification of novel proteins and biomarkers by harvesting proteins from specific subcellular locations for basic research and disease diagnostic applications.
more
Publication Icon
No publications yet
There aren’t any sponsored reports right now
Back to "All"
x